These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 50101)

  • 1. Heterogeneity of human circulating anticoagulants against antihemophilic factor (factor VIII).
    Poon MC; Wine AC; Ratnoff OD; Bernier GM
    Blood; 1975 Sep; 46(3):409-16. PubMed ID: 50101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Techniques for demonstration of the specificity of circulating anticoagulants against antihemophilic factor (factor VIII), with studies of two cases possibly related to diphenylhydantoin therapy.
    Poon MC; Saito H; Ratnoff OD; Forman WB; Wisnieski J
    Blood; 1977 Mar; 49(3):477-82. PubMed ID: 836956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunological characterization of human antibodies to factor VIII isolated by immuno-affinity chromatography.
    Kavanagh ML; Wood CN; Davidson JF
    Thromb Haemost; 1981 Feb; 45(1):60-4. PubMed ID: 6787728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two myeloma globulins, IgG1-kappa and IgG1-lambda, from a single patient (Im). I. Purification and immunochemical characterization.
    Oriol R; Huerta J; Bouvet JP; Liacopoulos P
    Immunology; 1974 Dec; 27(6):1081-93. PubMed ID: 4141693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.
    Zimmerman TS; Ratnoff OD; Powell AE
    J Clin Invest; 1971 Jan; 50(1):244-54. PubMed ID: 5543879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating anticoagulant in patients with hemophilia A.
    Uszyński L; Lopaciuk S
    Pol Med J; 1969; 8(4):862-9. PubMed ID: 4105591
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic studies of antihemophilic factor (AHF, factor VIII). 3. Comparative binding properties of human and rabbit anti-AHF.
    Hoyer LW
    Blood; 1972 Apr; 39(4):481-9. PubMed ID: 4622205
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating anticoagulant in a family with prolonged bleeding time and factor VIII deficiency.
    Diez-Ewald M; Lian EC; Nunez R; Deykin D; Harkness DR
    Blood; 1977 May; 49(5):799-806. PubMed ID: 851643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunoglobulin light chain subgroups: serological typing.
    Rivat L; Rivat C; Ropartz C
    Ann Immunol (Paris); 1974; 125 C(5):697-703. PubMed ID: 4142370
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of a factor-VIII inhibitor in a non-hemophylic patient and in a patient with hemophylia A gravis].
    Mayer C; Kalogjera V; Lievre C; Pautler J; Weisel ML; Mayer S
    Sem Hop; 1977 Jul 10-20; 53(25-28):1511-6. PubMed ID: 19846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.
    BRECKENRIDGE RT; RATNOFF CD
    Blood; 1962 Aug; 20():137-49. PubMed ID: 13872719
    [No Abstract]   [Full Text] [Related]  

  • 14. A circulating anticoagulant selectively active against human antihemophilic factor (autoimmune hemophilia).
    SPAET TH; KINSELL BG
    Stanford Med Bull; 1954 Nov; 12(4):246-56. PubMed ID: 13225986
    [No Abstract]   [Full Text] [Related]  

  • 15. Surface immunoglobulins on mouse myeloma cells.
    Princler GL; McIntire KR
    Cell Immunol; 1975 Jan; 15(1):197-207. PubMed ID: 45838
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic properties of antihemophilic factor.
    Hoyer LW
    Prog Hematol; 1973; 8():191-221. PubMed ID: 4545112
    [No Abstract]   [Full Text] [Related]  

  • 17. [Circulating anticoagulant in hemophilia A: laboratory evidence of a coagulation factor 8 inhibitor].
    Hule V
    Vnitr Lek; 1967 Sep; 13(9):859-65. PubMed ID: 6081657
    [No Abstract]   [Full Text] [Related]  

  • 18. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L
    Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
    Allain JP; Gaillandre A; Lee H
    J Lab Clin Med; 1981 Jun; 97(6):791-800. PubMed ID: 6785371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on fd fragments of human immunoglobulins. III. Immunogenic properties of gamma chains, myeloma fd gamma, and myeloma fd1 alpha.
    Zegers JM; Ballieux RE; van Loghem E
    Scand J Immunol; 1975; 4(2):161-9. PubMed ID: 806961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.